- Previous Close
94.53 - Open
94.53 - Bid 94.29 x 40000
- Ask 94.41 x 40000
- Day's Range
94.53 - 94.53 - 52 Week Range
89.39 - 115.85 - Volume
111 - Avg. Volume
11,370 - Market Cap (intraday)
12.341B - Beta (5Y Monthly) 0.46
- PE Ratio (TTM)
55.80 - EPS (TTM)
1.69 - Earnings Date Feb 13, 2025
- Forward Dividend & Yield 1.35 (1.43%)
- Ex-Dividend Date Sep 18, 2024
- 1y Target Est
--
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
www.cochlear.comRecent News: CHEOY
View MorePerformance Overview: CHEOY
Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CHEOY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CHEOY
View MoreValuation Measures
Market Cap
12.32B
Enterprise Value
12.15B
Trailing P/E
55.94
Forward P/E
47.62
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.93
Price/Book (mrq)
10.80
Enterprise Value/Revenue
8.75
Enterprise Value/EBITDA
33.81
Financial Highlights
Profitability and Income Statement
Profit Margin
15.96%
Return on Assets (ttm)
11.99%
Return on Equity (ttm)
19.88%
Revenue (ttm)
2.24B
Net Income Avi to Common (ttm)
356.8M
Diluted EPS (ttm)
1.69
Balance Sheet and Cash Flow
Total Cash (mrq)
513.6M
Total Debt/Equity (mrq)
13.24%
Levered Free Cash Flow (ttm)
246.05M